相似文献
1
Diabetic Retinopathy: Animal Models, Therapies, and Perspectives.
J Diabetes Res. 2016;2016:3789217. doi: 10.1155/2016/3789217. Epub 2016 Jan 6.
2
Animal Models of Diabetic Retinopathy.
Curr Eye Res. 2015;40(8):761-71. doi: 10.3109/02713683.2014.964415. Epub 2015 Apr 2.
3
Current Approaches in Treatment of Diabetic Retinopathy and Future Perspectives.
J Ocul Pharmacol Ther. 2020 Sep;36(7):487-496. doi: 10.1089/jop.2019.0137. Epub 2020 May 21.
4
Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals.
Dis Model Mech. 2012 Jul;5(4):444-56. doi: 10.1242/dmm.009597.
5
The Mechanism of Diabetic Retinopathy Pathogenesis Unifying Key Lipid Regulators, Sirtuin 1 and Liver X Receptor.
EBioMedicine. 2017 Aug;22:181-190. doi: 10.1016/j.ebiom.2017.07.008. Epub 2017 Jul 11.
6
Mesenchymal stromal/stem cells as potential therapy in diabetic retinopathy.
Immunobiology. 2018 Dec;223(12):729-743. doi: 10.1016/j.imbio.2018.01.001. Epub 2018 Feb 15.
7
Systemic considerations in the management of diabetic retinopathy.
Am J Ophthalmol. 2001 Nov;132(5):760-76. doi: 10.1016/s0002-9394(01)01124-2.
8
Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence.
Prog Retin Eye Res. 2015 Sep;48:160-80. doi: 10.1016/j.preteyeres.2015.04.003. Epub 2015 Apr 30.
9
Basigin can be a therapeutic target to restore the retinal vascular barrier function in the mouse model of diabetic retinopathy.
Sci Rep. 2016 Dec 5;6:38445. doi: 10.1038/srep38445.
10
Adult Stem Cell Therapeutics in Diabetic Retinopathy.
Int J Mol Sci. 2019 Sep 30;20(19):4876. doi: 10.3390/ijms20194876.
引用本文的文献
1
AI-Enhanced Fluorescein Angiography Detection of Diabetes-Induced Silent Retinal Capillary Dropout and RNA-Seq Identification of Pre-Symptomatic Biomarkers.
Biomedicines. 2025 Aug 7;13(8):1926. doi: 10.3390/biomedicines13081926.
2
Diabetic retinopathy and Alzheimer's disease: Convergence of the unfolded protein response in neurodegeneration.
Alzheimers Dement. 2025 Aug;21(8):e70497. doi: 10.1002/alz.70497.
3
Aberrant expression of TRIM44, transcriptionally regulated by KLF9, contributes to the process of diabetic retinopathy.
J Transl Med. 2025 Apr 11;23(1):433. doi: 10.1186/s12967-025-06436-z.
4
Peptide Lv and Angiogenesis: A Newly Discovered Angiogenic Peptide.
Biomedicines. 2024 Dec 15;12(12):2851. doi: 10.3390/biomedicines12122851.
5
Retinal OCT-Derived Texture Features as Potential Biomarkers for Early Diagnosis and Progression of Diabetic Retinopathy.
Invest Ophthalmol Vis Sci. 2025 Jan 2;66(1):7. doi: 10.1167/iovs.66.1.7.
6
Evaluation of the effect of melatonin treatment on telomere length of the retinal pigment epithelium in streptozotocin-induced diabetic rat model.
BMC Ophthalmol. 2024 Dec 18;24(1):532. doi: 10.1186/s12886-024-03732-y.
7
Diabetic macular edema (DME): dissecting pathogenesis, prognostication, diagnostic modalities along with current and futuristic therapeutic insights.
Int J Retina Vitreous. 2024 Oct 28;10(1):83. doi: 10.1186/s40942-024-00603-y.
8
Progress in experimental models to investigate the in vivo and in vitro antidiabetic activity of drugs.
Animal Model Exp Med. 2024 Jun;7(3):297-309. doi: 10.1002/ame2.12442. Epub 2024 Jun 4.
9
Comparative evaluation of trypsin and elastase digestion techniques for isolation of murine retinal vasculature.
Microvasc Res. 2024 Jul;154:104682. doi: 10.1016/j.mvr.2024.104682. Epub 2024 Mar 21.
10
Synergism of mechanisms underlying early-stage changes in retina function in male hyperglycemic db/db mice in the absence and presence of chemically-induced dyslipidemia.
Sci Rep. 2023 Oct 13;13(1):17347. doi: 10.1038/s41598-023-44446-3.
本文引用的文献
1
Opportunities for Nano-Formulations in Type 2 Diabetes Mellitus Treatments.
Curr Pharm Biotechnol. 2015;16(10):853-70. doi: 10.2174/1389201016666150727120618.
2
The use of fenofibrate in the management of patients with diabetic retinopathy: an evidence-based review.
Aust Fam Physician. 2015 Jun;44(6):367-70.
3
Diabetic Retinopathy: Vascular and Inflammatory Disease.
J Diabetes Res. 2015;2015:582060. doi: 10.1155/2015/582060. Epub 2015 Jun 7.
4
Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy.
Proc Natl Acad Sci U S A. 2015 Jun 9;112(23):E3030-9. doi: 10.1073/pnas.1423765112. Epub 2015 May 26.
5
Applications of nanoparticles in nanomedicine.
J Biomed Nanotechnol. 2014 Sep;10(9):2371-92. doi: 10.1166/jbn.2014.2015.
6
Diabetic retinopathy: recent advances towards understanding neurodegeneration and vision loss.
Sci China Life Sci. 2015 Jun;58(6):541-9. doi: 10.1007/s11427-015-4856-x. Epub 2015 May 8.
7
Imaging in diabetic retinopathy.
Middle East Afr J Ophthalmol. 2015 Apr-Jun;22(2):145-50. doi: 10.4103/0974-9233.151887.
8
Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence.
Prog Retin Eye Res. 2015 Sep;48:160-80. doi: 10.1016/j.preteyeres.2015.04.003. Epub 2015 Apr 30.
9
Diabetic Macular Edema: Pathophysiology and Novel Therapeutic Targets.
Ophthalmology. 2015 Jul;122(7):1375-94. doi: 10.1016/j.ophtha.2015.03.024. Epub 2015 Apr 30.
10
Protective effect of a Chinese Medicine formula He-Ying-Qing-Re Formula on diabetic retinopathy.
J Ethnopharmacol. 2015 Jul 1;169:295-304. doi: 10.1016/j.jep.2015.04.031. Epub 2015 Apr 28.
Zotero 插件